In-Depth Metaproteomics Analysis of Oral Microbiome for Lung Cancer

• Published in: Research (Washington) Vol. 2022; p. 9781578
• Main Authors: Jiang, Xiaoteng, Zhang, Yan, Wang, Huiyu, Wang, Zeyuan, Hu, Shen, Cao, Chengxi, Xiao, Hua
• Format: Journal Article
• Language: English
• Published: AAAS 2022; American Association for the Advancement of Science (AAAS)
• ISSN: 2639-5274; 2639-5274
• DOI: 10.34133/2022/9781578

The human oral microbiome correlates with numerous diseases, including lung cancer. Identifying the functional changes by metaproteomics helps understand the disease-related dysbiosis, yet characterizing low-abundant bacteria is challenging. Here, we developed a free-flow isoelectric focusing electrophoresis-mass spectrometry- (FFIEF-MS-) based metaproteomics strategy to reduce host interferences and enrich low-abundant bacteria for in-depth interpretation of the oral microbiome. With our method, the number of interfering peptides decreased by 52.87%, whereas the bacterial peptides and species increased by 94.97% and 44.90%, respectively, compared to the conventional metaproteomics approach. We identified 3647 bacterial proteins, which is the most comprehensive oral metaproteomics study to date. Lung cancer-associated bacteria were validated among an independent cohort. The imbalanced Fusobacterium nucleatum and Prevotella histicola and their dysregulated functions in inhibiting immune response and maintaining cell redox homeostasis were revealed. The FFIEF-MS may serve as a valuable strategy to study the mechanisms between human diseases and microbiomes with broader applications.